StageBio Freiburg provides GLP-compliant and specialist histopathology, biomarker, and pathology services for preclinical and nonclinical studies. Our facility supports scientifically rigorous decision-making, regulatory-ready documentation, and seamless collaboration across international programs.
Immunofluorescence (IF) for fluorescent biomarker localization
In situ hybridization (ISH) for spatial RNA/DNA target detection
Specialized Services
Therapeutic antibody tissue cross-reactivity (TCR) studies with species-relevant tissue panels
Tissue biobank (FFPE and OCT snap-frozen tissues: human, NHP, rat, mouse, rabbit)
Digital image analysis and quantification for reproducible tissue endpoints
In vitro histology for organoids and in vitro models
Pathology Services
Board-certified pathologist review and evaluation across therapeutic areas, modalities, and disease indications
Supporting Preclinical & Nonclinical Study Needs
GLP & Non-GLP Studies
IND-enabling Studies & Preclinical Testing
Safety Pharmacology & Toxicity Assessment
Biocompatibility Assessment
Regulatory Submission Support (including SEND-aligned data inputs)
CRO Management, Outsourcing, & Vendor Evaluation Support
Quality & Regulatory Readiness
Documented Workflows & SOP-driven Processes
Sample Traceability & Data Provenance
Clear Separation of GLP & Non-GLP Activities
Pathology Reports Structured for Regulatory Review
Audit-ready Documentation Available on Request
Our Commitment to Sustainability
StageBio has been awarded a Gold rating in our first EcoVadis sustainability assessment, placing our European operations in the top 5% of all companies evaluated worldwide. EcoVadis is one of the world's most trusted providers of business sustainability ratings, assessing companies across environmental impact, labor and human rights, ethics, and sustainable procurement.
This achievement reflects the policies, practices, and people already in place across our organization, and it marks the beginning of a broader commitment. As we continue to grow, we are investing in the systems and transparency needed to raise our sustainability performance year over year.
Why Choose Freiburg?
Preclinical & Nonclinical Focus
Specialist histopathology services designed to support toxicology, safety assessment, and IND-enabling studies
Scientist & Pathologist-led
Direct access to experienced histologists and board-certified pathologists for study planning and interpretation
Regulatory-ready Outputs
Documentation, traceability, and reporting structured to support regulatory review and due diligence
Advanced Biomarker Capability
IHC, multiplex IHC, IF, ISH, tissue cross-reactivity studies, and quantitative digital pathology
Integrated Tissue Workflows
From processing and staining to digital image analysis, pathology review, and archiving under one roof
Built for Collaboration
Supports biotech, pharma, CRO partners, consultants, and international development teams
Want to learn more about what we do?
Visit our Company Overview page to discover the full range of services StageBio offers and how we can support your research goals.
Whether you are planning an IND-enabling study, setting up a biomarker assay, or reviewing pathology strategy for a safety program, our Freiburg specialists can help scope the right approach.
Preclinical and nonclinical histopathology services supporting toxicology, safety assessment, and IND-enabling drug development programs.
513.204.4400
